Skip to main content

Table 1 Clinical characteristics at baseline of study participants

From: Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions

 

All

DM

Non-DM

P-value

Subject number

237

73

164

NA

Age (years)

54 ± 16

55 ± 17

52 ± 15

0.174

Males

165 (70)

50 (68)

115 (70)

0.801

BMI, kg/m2

25.2 ± 4.6

25.3 ± 4.5

24.8 ± 4.2

0.409

LVEF, %

53.9 ± 7.3

53.5 ± 7.1

54.2 ± 7.4

0.497

Systolic BP (mm Hg)

120 ± 21

123 ± 25

118 ± 23

0.134

Diastolic BP (mm Hg)

70 ± 9

69 ± 10

71 ± 12

0.215

Serum creatinine, mg/dL

0.80 ± 0.22

0.82 ± 0.21

0.78 ± 0.19

0.149

Total Cholesterol (mmol/l)

4.64 ± 1.05

4.56 ± 1.01

4.69 ± 1.09

0.387

Triglycerides (mmol/l)

2.23 ± 1.28

2.36 ± 1.65

1.97 ± 1.03

0.036

LDL-C (mmol/l)

2.87 ± 1.10

2.82 ± 1.13

2.91 ± 1.18

0.584

HDL-C (mmol/l)

0.98 ± 0.31

0.95 ± 0.22

1.01 ± 0.35

0.178

HbA1c (%)

6.5 ± 1.3

7.1 ± 1.2

6.1 ± 1.0

<0.001

Glycated albumin (%)

17.8 ± 7.6

21.2 ± 6.7

12.9 ± 4.5

<0.001

Peak cTNI (ng/ml)

37.3 ± 10.7

40.5 ± 11.4

36.2 ± 12.5

0.013

Peak CK-MB (ng/ml)

37.8 ± 15.6

39.4 ± 17.5

36.2 ± 16.4

0.176

FBG (mmol/l)

7.3 ± 2.8

8.8 ± 2.4

6.1 ± 1.7

<0.001

Management of DM (%)

    

OHA

 

25 (34.2)

  

Insulin only

 

31 (42.5)

  

Insulin + OHA (s)

 

17 (23.3)

  

Risk factors (n, %)

    

Hyperlipidemia

93 (39)

32 (43.8)

61 (37.2)

0.334

Hypertension

95 (40)

30 (41.1)

65 (39.6)

0.832

Current smoking

106 (45)

30 (41.1)

76 (46.3)

0.453

Family history

29 (12)

8 (11)

21 (13)

0.689

Obesity

55 (23)

20 (27)

35 (21)

0.308

CGMS parameters on the first day

    

MBG (mmol/l)

8.1 ± 2.6

10.6 ± 2.3

6.7 ± 1.1

<0.001

MAGE (mmol/l)

3.6 ± 2.0

3.9 ± 1.1

2.8 ± 1.6

<0.001

SDBG (mmol/l)

1.7 ± 1.0

2.5 ± 1.3

1.3 ± 0.7

<0.001

Angiographic data (n, %)

    

Single vessel

92 (39)

21 (29)

71 (43.3)

0.034

Double vessels

77 (32)

27 (37)

50 (30.5)

0.324

Triple vessels

68 (29)

25 (34)

43 (26.2)

0.207

Main stem involved

32 (14)

12 (16)

20 (12)

0.378

Multivessel

145 (61)

52 (71)

93 (57)

0.034

  1. Data given as mean ± SD or n (%).
  2. BMI, body mass index; LVEF, left ventricular ejection fraction; LDL-C, Low density lipoprotein-cholesterol; HDL-C, High density lipoprotein-cholesterol; HbA1c, hemoglobin A1c; CK-MB, creatine kinase-MB; cTnI, cardiac troponin I; FBG, fasting blood glucose; OHA, oral hypoglycaemic agent; MBG, Mean blood glucose; MAGE, the mean amplitude of glycemic excursions; SDBG, the standard deviation of blood glucose values.
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us